Pay in 4 interest-free payments of $6.78 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
The Data: In recent Phase 3 trials, patients on the highest dose lost an average of 28.7% of their body weight
:max_bytes(150000):strip_icc()/GettyImages-1472399442-33242d042c8c4776b4ac9e2133de7b59.jpg)
Theyre one helpful tool in your larger healthcare toolbox
Add air first
The bottom line on formulations If you are breastfeeding and your physician approves GLP-1 therapy, only injectable formulations should be considered
The exact cause of pernicious anaemia is unknown, but it's more common in women around 60 years of age, people with a family history of the condition and those with another autoimmune condition, such as Addison's disease or vitiligo
Long half-life acylation and albumin binding Acylation with the C20 chain causes the molecule to bind to plasma albumin after administration, which significantly extends the time of its presence in the bloodstream
US$ 22.68
US$ 28.43
US$ 27.80
